NCT06831838NARecruiting
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
Mayo Clinic
Start Date
2/6/2025
Completion Date
12/31/2026
Summary
The purpose of this research is to evaluate the effectiveness of a multidisciplinary pain management program for AIMSS in reducing pain, subjective cognitive complaints, psychological distress, and impaired functional status resulting in improved adherence to Aromatase Inhibitor medications compared to usual care. We want to identify predictors of improvement in pain, functional status, subjective cognition and mood following participation in the program.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* At least 18 years old
* ECOG ≤ 2
* Stage 0-III HR+ breast cancer in need of strategies to reduce symptoms and improve quality of life
Exclusion Criteria:
• Less than 18 years of age.
\- Stage 4 HR+ breast cancer
Interventions
BEHAVIORAL
Cognitive Behavioral Therapy based Pain Management Program
Conditions
Breast Cancer
Locations
Mayo Clinic in Florida
Jacksonville, Florida 32224
United States